Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
1 result
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Good efficacy achieved by baricitinib in the treatment of anti-MDA5 antibody-positive dermatomyositis with alopecia areata.
Rheumatology (Oxford). 2022 Aug 3;61(8):e221-e223. doi: 10.1093/rheumatology/keac084.
Rheumatology (Oxford). 2022.
PMID: 35148369
No abstract available.
Cite
Cite